πŸ‡ΊπŸ‡Έ FDA

Intelligence Β· Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors β€” phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
20,548
Companies
1,769
Drugs tracked
4,797

Quick answer

NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β€” searchable for business development and competitive intelligence.

5,027 results for β€œERA” Clear

  1. Propranolol Hydrochloride

    United Therapeutics Europe Ltd

    Post-traumatic Stress Disorder

    small molecule terminated

    1 trial
  2. Prostate biopsy

    United Therapeutics Europe Ltd

    Prostate Cancer

    other active

    1 trial
  3. Protocol-based management of perioperative antithrombotic therapy

    Peking University Third Hospital

    Antithrombotic Therapy

    small molecule active

    1 trial
  4. Protocol-based management of perioperative antithrombotic therapy

    The First People's Hospital of Lianyungang

    Antithrombotic Therapy

    small molecule active

    1 trial
  5. Prunes

    United Therapeutics Europe Ltd

    Perimenopausal Bone Loss

    other active

    1 trial
  6. Pueraria lobata radix

    The First People's Hospital of Lianyungang

    Type 2 Diabetes Mellitus

    small molecule active

    1 trial
  7. Pyridoxal-5'-Phosphate supplement

    AVENUE THERAPEUTICS, INC.

    Neural Inhibition

    small molecule active

    1 trial
  8. Qingre Huashi Granules combined the modified dual therapy

    The First People's Hospital of Lianyungang

    Helicobacter Pylori Infection

    small molecule active

    1 trial
  9. RSV A Memphis 37

    United Therapeutics Europe Ltd

    Respiratory Syncytial Virus Infections

    mab completed

    1 trial
  10. Radiation therapy

    United Therapeutics Europe Ltd

    Breast Cancer

    other completed

    1 trial
  11. Radiotherapy combined with TKI and Anti-PD-1 Antibody

    Jian Li

    Stage IIIA Hepatocellular Carcinoma

    other active

    1 trial
  12. Rapid test for diagnosis orientation

    Grace Therapeutics

    Flu

    other active

    1 trial
  13. Ready to Use Supplementary Food

    United Therapeutics Europe Ltd

    Moderate Acute Malnutrition

    other completed

    1 trial
  14. Ready-to-use school food

    United Therapeutics Europe Ltd

    School Attendance

    other active

    1 trial
  15. Ready-to-use therapeutic food (RUTF)

    United Therapeutics Europe Ltd

    Severe Acute Malnutrition

    other terminated

    1 trial
  16. Regional lymph node radiotherapy (RNI) including the axilla

    The First People's Hospital of Lianyungang

    Axillary Lymph Node Dissection

    other active

    1 trial
  17. Rehabilitation Therapy as part of Standard of Care (Control)

    BRIGHT MINDS BIOSCIENCES INC.

    Acute Stroke

    gene therapy completed

    1 trial
  18. Remifentanil

    Vera Therapeutics

    Postoperative Pain

    small molecule completed

    1 trial
  19. Remodulin

    United Therapeutics Europe Ltd

    Congenital Heart Disease

    small molecule terminated

    1 trial
  20. Resveratrol, curcumin

    Atrium Therapeutics

    Effect of Resveratrol and Curcumin on Inflammation

    other completed

    1 trial
  21. Rifaximin

    United Therapeutics Europe Ltd

    Tropical Enteropathy

    small molecule completed

    1 trial
  22. Rifaximin

    United Therapeutics Europe Ltd

    Travelers' Diarrhea

    small molecule completed

    1 trial
  23. Rituximab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Peripheral T-Cell Lymphoma, Not Otherwise Specified

    small molecule active

    1 trial
  24. Ropivacaine

    Zealand Pharma A/S

    Pain, Postoperative

    small molecule terminated

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β€” verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources